Redmile Group’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
|
|||||
|
2025
Q2 | $8.31M | Sell |
|
|||||
|
2025
Q1 | $5.52M | Sell |
|
|||||
|
2024
Q4 | $7.43M | Sell |
|
|||||
|
2024
Q3 | $6.7M | Sell |
|
|||||
|
2024
Q2 | $7.14M | Sell |
|
|||||
|
2024
Q1 | $21.3M | Sell |
|
|||||
|
2023
Q4 | $24M | Buy |
|
|||||
|
2023
Q3 | $10.7M | Sell |
|
|||||
|
2023
Q2 | $19.9M | Sell |
|
|||||
|
2023
Q1 | $16.2M | Sell |
|
|||||
|
2022
Q4 | $23.6M | Sell |
|
|||||
|
2022
Q3 | $51.7M | Sell |
|
|||||
|
2022
Q2 | $28M | Sell |
|
|||||
|
2022
Q1 | $41.9M | Buy |
|
|||||
|
2021
Q4 | $63M | Sell |
|
|||||
|
2021
Q3 | $87.8M | Sell |
|
|||||
|
2021
Q2 | $117M | Buy |
|